Purchase Order 19GG8025P0470
Award Date
7/21/25
Potential Completion Date
8/29/25
Potential Value
$128K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
US Embassy Tbilisi
Awardee
Elta 90 Medical Genetics LLC
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Georgia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
7
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a $30,890 firm-fixed-price delivery order to Elta 90 Medical Genetics LLC, a small business joint venture, for the supply of MISEQ REAGENT KIT V2 500 CYCLE. This award is part of a single-award Indefinite Delivery Contract (IDC) held by Elta 90 Medical Genetics LLC with the Defense Health Agency, with a ceiling value of $688,126 and an ultimate completion date of December 31, 2027. The IDC is for the procurement of MINISEQ DEVICE, indicating that Elta 90 Medical...
Elta 90 Medical Genetics LLC has been awarded a $122,000 firm fixed price purchase order by the Defense Advanced Research Projects Agency (DARPA) to provide WRAIR_ILLUMINA MISEQ services. The contract has a period of performance from August 17, 2023 through September 30, 2023, with work to be conducted in Gürcistan. DARPA's high-level programs involve advancing technologies with potential military applications, suggesting this contract supports research using next-generation DNA sequencing...
The Defense Health Agency awarded a firm-fixed-price purchase order contract to Elta 90 Medical Genetics LLC, a small business joint venture, for the WRAIR_MISEQ MAINTENANCE CONTRACT. The contract has a ceiling value of $120,059 and a period of performance through March 19, 2026. Elta 90 Medical Genetics LLC is a for-profit limited liability company that specializes in providing genetic sequencing equipment, supplies, and maintenance services to defense agencies. This contract is not set aside...
<p>The WRAIR_MISEQ_MAINTENANCE CONTRACT is a federal purchase order awarded by the Defense Advanced Research Projects Agency (DARPA) to Elta 90 Medical Genetics LLC, a for-profit limited liability company. The contract is for firm fixed-price maintenance services and has a potential value of $69,720.00. The contract does not have a set-aside designation and will be performed in Georgia. The contract has a completion date of February 14, 2025.</p>
This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $680,732.58, is for the delivery of a MiSeq FGx Sequencing System, which supports genetic and genomic analysis. The contract has no set-aside designation. Illumina has a history of providing sequencing systems and related goods and services to various federal agencies such as the National...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and analytical instrumentation and reagents. The contract, valued at $95,931.00, is for the procurement of an SY-410-1003 ASSY, TLA, MISEQ2 item. The contract has no set-aside designation and is intended to support Illumina's provision of sequencing systems, reagents, and services to MEDCOM and its research activities. Illumina has a history of...
This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
This is a firm fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $95,931.00, is for the delivery of a MiSeq System, a DNA sequencing instrument used for genomic research and diagnostics. While Illumina has previously received prime contract and sub-contract awards from other federal agencies such as the NIH, CDC, USDA, and VA to provide a range of its sequencing...
This is a firm fixed price purchase order contract awarded by the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and consumables. The $80,467.62 contract is for providing maintenance services on Illumina's MiSeq sequencing system to support the agency's research activities at its facility in Athens, Georgia. The contract has a 5-year term from the November 2023 award date through January...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $581,761.93, is for the provision of support plans and reagent kits for the NextSeq equipment located at the Walter Reed Army Institute of Research (WRAIR) facility in Silver Spring, Maryland. The contract has an ultimate completion date of October 1, 2024....